Researchers have determined that a genetic alteration can provide almost complete protection against malaria, which in Africa kills 3000 children each day. The alteration produces a form of the oxygen-transport molecule called hemoglobin C that seems to have no adverse effects. Understanding how hemoglobin C works could help guide the development of vaccines and drugs, malaria researchers say.